Canagliflozin and Fluticasone propionate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Canagliflozin (canagliflozin) and Fluticasone propionate (fluticasone propionate). Common drug interactions include hospitalisation among females and adverse drug reaction among males.
The phase IV clinical study analyzes what interactions people have when they take Canagliflozin and Fluticasone propionate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Canagliflozin?
Canagliflozin has active ingredients of canagliflozin. eHealthMe is studying from 3,253 Canagliflozin users. Check the latest studies of Canagliflozin.
What is Fluticasone propionate?
Fluticasone propionate has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 35,174 Fluticasone propionate users. Check the latest studies of Fluticasone propionate.
14 people who take Canagliflozin and Fluticasone propionate together, and have interactions are studied.

What are the common drug interactions of Canagliflozin and Fluticasone Propionate, by gender? *:
female:
- Hospitalisation
- Memory impairment
- Cystitis (inflammation of the wall of the bladder)
- Spinal fusion surgery
- Blood immunoglobulin e increased
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
- Cough
- Dyspnoea (difficult or laboured respiration)
- Malignant mediastinal neoplasm (cancerous growths that form in the area of the chest that separates the lungs)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
male:
- Adverse drug reaction
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Hypotension (abnormally low blood pressure)
- Ocular myasthenia (a disease of the neuromuscular junction resulting in hallmark variability in muscle weakness and fatigability)
- Pancreatitis acute (sudden inflammation of pancreas)
- Post streptococcal glomerulonephritis (inflammation of the kidney tubules)
- Anxiety
- Bone density decreased
What are the common drug interactions of Canagliflozin and Fluticasone Propionate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Cystitis (inflammation of the wall of the bladder)
- Hospitalisation
- Memory impairment
- Spinal fusion surgery
50-59:
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Thirst
60+:
- Adverse drug reaction
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Cough
- Dyspnoea (difficult or laboured respiration)
- Extradural abscess (pus may gather between a patient's skull and his dura)
- Glycosylated haemoglobin increased
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Hypotension (abnormally low blood pressure)
- Malignant mediastinal neoplasm (cancerous growths that form in the area of the chest that separates the lungs)
What are the existing conditions these people have? *
- Ill-Defined Disorder: 4 people, 28.57%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 21.43%
- Hiv Infection: 2 people, 14.29%
- Type 2 Diabetes: 1 person, 7.14%
- Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 7.14%
- Pneumonia: 1 person, 7.14%
- Diabetes: 1 person, 7.14%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Canagliflozin and Fluticasone propionate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Canagliflozin (3,253 reports)
- Fluticasone propionate (35,174 reports)
Browse all drug interactions of Canagliflozin and Fluticasone propionate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Canagliflozin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fluticasone propionate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Canagliflozin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fluticasone propionate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
- Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on canagliflozin and fluticasone propionate (the active ingredients of Canagliflozin and Fluticasone propionate, respectively), and Canagliflozin and Fluticasone propionate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Maxipime and Hydroxyzine - 16 seconds ago
- Could Morphine Sulfate cause Personality Disorder? - 19 seconds ago
- Bextra and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Girls aged 10-19 - 25 seconds ago
- Bextra and Weariness for Girls aged 10-19 - 25 seconds ago
- Bextra and Tiredness for Girls aged 10-19 - 26 seconds ago
- Bextra and Lethargy for Girls aged 10-19 - 26 seconds ago
- Bextra and Exhaustion for Girls aged 10-19 - 26 seconds ago
- Bextra and Fatigue for Girls aged 10-19 - 27 seconds ago
- Could Detrol La cause Muscle Cramps Aggravated? - 27 seconds ago
- Drug interactions of Docetaxel and Oncovin - 34 seconds ago